|
Genecopoeia
eif4e complementary cdna Eif4e Complementary Cdna, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/eif4e+complementary+cdna/eIF4E+Rabbit+mAb/pm37217473-58-7-29 Average 95 stars, based on 1 article reviews
eif4e complementary cdna - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
Ribobio co
eif4e cdna ![]() Eif4e Cdna, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/eif4e+complementary+cdna/sirnas+targeting+dlat++eif4e++and+sp1/pmc05356753-193-0-18 Average 90 stars, based on 1 article reviews
eif4e cdna - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: A. The expression of eIF4E in normal colon tissues around cancer. B. The negative expression of eIF4E in colon cancerous tissues. C. The positive expression of eIF4E in colon cancerous tissues. D. The expression of VEGF-C in normal colon tissues around cancer. E. The negative expression of VEGF-C in colon cancerous tissues. F. The positive expression of VEGF-C in colon cancerous tissues. G. The expression of E-cadherin (E-cad) in normal colon tissues around cancer. H. The negative expression of E-cad in colon cancerous tissues. I. The positive expression of E-cad in colon cancerous tissues. J. The expression of MMP-2 in normal colon tissues around cancer. K. The negative expression of MMP-2 in colon cancerous tissues. L. The positive expression of MMP-2 in colon cancerous tissues. Bar = 50 μM.
Article Snippet:
Techniques: Expressing
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: Relationship between the expression of eIF4E, VEGF-C, E-cadherin and MMP-2 as well as clinical pathological parameters
Article Snippet:
Techniques: Expressing
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: Log rank test χ2= 75.0054. p< 0.0001. Fragments of human colon tumors were implanted subcutaneously (s.c.) into nude mice, and mice with tumors that reached 4–5 mm in diameter (n=5 per group) were applied to survival statistics. A. Kaplan–Meier survival curves of mice bearing eIF4E negative and positive tumors. B. Kaplan–Meier survival curves of mice bearing VEGF-C negative and positive tumors. C. Kaplan–Meier survival curves of mice bearing MMP-2 negative and positive tumors. D. Kaplan–Meier survival curves of mice bearing E-cadherin negative and positive tumors.
Article Snippet:
Techniques:
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: A. The negative expression of eIF4E in colon cancerous tissues. B. The positive expression of eIF4E in colon cancerous tissues. C. The negative expression of VEGF-C in colon cancerous tissues. D. The positive expression of VEGF-C in colon cancerous tissues. E. The negative expression of E-cadherin in colon cancerous tissues. F. The positive expression of E-cadherin in colon cancerous tissues. G. The negative expression of MMP-2 in colon cancerous tissues. H. The positive expression of MMP-2 in colon cancerous tissues. Bar = 25 μM.
Article Snippet:
Techniques: Expressing
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: A. Western blotting showed that the stable cell lines including HCT-15/Rluc/E-cadherin, HCT-15/Rluc/VEGF-C, HCT-15/Rluc/MMP-2, and HCT-15/Rluc/eIF4E were constructed successfully. B. The stable colon cancer cell lines with overexpression of E-cadherin, MMP-2, VEGF-c and eIF4E as well as parental HCT-15/Rluc cell line showed different growth rates.
Article Snippet:
Techniques: Western Blot, Stable Transfection, Construct, Over Expression
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: A. The HCT-15/Rluc/eIF4E cells (1.0 × 10 6 ) and corresponding HCT-15-Rluc were injected via tail-vein 3 days later. The bioluminescence seen represents the thorax region of the mouse where HCT-15/Rluc and HCT-15/Rluc/eIF4E cells are trapped in the lungs. B. The HCT-15/Rluc/VEGF-C cells (1.0 × 10 6 ) and corresponding HCT-15/Rluc were injected via tail-vein 3 days later. The bioluminescence seen represents the thorax region of the mouse where HCT-15/Rluc and HCT-15/Rluc/VEGF-C cells are trapped in the lungs. C. The HCT-15/Rluc/MMP-2 cells (1.0 × 10 6 ) and corresponding HCT-15/Rluc were injected via tail-vein 3 days later. The bioluminescence seen represents the thorax region of the mouse where HCT-15/Rluc and HCT-15/Rluc/MMP-2 cells are trapped in the lungs. D. The HCT/15-Rluc/E-cadherin cells (1.0 × 10 6 ) and corresponding HCT-15-Rluc were injected via tail-vein 3 days later. The bioluminescence seen represents the thorax region of the mouse where HCT-15/Rluc and HCT-15/Rluc/E-cadherin cells are trapped in the lungs.
Article Snippet:
Techniques: Injection
Journal: Oncotarget
Article Title: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
doi: 10.18632/oncotarget.13453
Figure Lengend Snippet: A. Western blotting showed the expression of eIF4E, VEGF-C, MMP-2, and E-cadherin in the corresponding stable SW 480 cell lines with the overexpression and knockdown of eIF4E. Control, Control stable SW480 cell lines by use of lentiviral infection packaged with control empty vectors. Overexpression, the stable SW480 cell line with the overexpression of eIF4E. sheIF4E, the stable SW480 cell lines with knockdown of eIF4E. The cells were lysed for loading on SDS-PAGE. The blotting were performed by use of indicated antibodies. B. Q-PCR showed the expression of eIF4E, VEGF-C, MMP-2, and E-cadherin in the stable SW 480 cell lines with the overexpression of eIF4E. C. Q-PCR showed the expression of eIF4E, VEGF-C, MMP-2, and E-cadherin in the stable SW 480 cell lines with the knockdown of eIF4E. Control, Control stable SW480 cell lines by use of lentiviral infection packaged with control empty vectors. Overexpression of eIF4E, the stable SW480 cell line with the overexpression of eIF4E. sheIF4E, the stable SW480 cell lines with knockdown of eIF4E. *, p<0.05. D. Relative number of migrating cells ( y -axis) in a transwell migration assay is shown for Control, eIF4E-overexpression, and eIF4E-knockdown SW 480 cells. *, p<0.05. E. Number of mammospheres ( y -axis) formed by Control, eIF4E-overexpression and eIF4E-knockdown SW480 cells. *, p<0.05.
Article Snippet:
Techniques: Western Blot, Expressing, Over Expression, Knockdown, Control, Infection, SDS Page, Transwell Migration Assay